- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 11/00 - Depsipeptides ayant jusqu'à 20 amino-acides dans une séquence entièrement déterminéeLeurs dérivés
Détention brevets de la classe C07K 11/00
Brevets de cette classe: 118
Historique des publications depuis 10 ans
|
4
|
5
|
6
|
9
|
10
|
9
|
4
|
3
|
8
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Onkure, Inc. | 28 |
5 |
| Sanofi | 4115 |
4 |
| Novartis AG | 10674 |
3 |
| The Regents of the University of California | 20211 |
3 |
| Massachusetts Institute of Technology | 10131 |
3 |
| Board of Regents, The University of Texas System | 5912 |
3 |
| President and Fellows of Harvard College | 6017 |
3 |
| Agency for Science, Technology and Research | 3661 |
2 |
| University of Florida Research Foundation, Inc. | 4068 |
2 |
| The Broad Institute, Inc. | 1862 |
2 |
| Chugai Seiyaku Kabushiki Kaisha | 1374 |
2 |
| Karus Therapeutics Limited | 27 |
2 |
| Nanyang Technological University | 2058 |
2 |
| Osaka Prefecture University Public Corporation | 239 |
2 |
| The Regents of the University of Colorado, a body corporate | 2698 |
2 |
| Shenzhen Institutes of Advanced Technology | 1496 |
2 |
| Stella Pharma Corporation | 38 |
2 |
| University of Vermont and State Agricultural College | 389 |
2 |
| The USA, as represented by the Secretary, Dept. of Health and Human Services | 85 |
2 |
| Sichuan Gooddoctor Panxi Pharmaceutical Co.,Ltd. | 26 |
2 |
| Autres propriétaires | 68 |